Adagen Market Report 2026

Adagen Market Overview

• The Adagen market growth in the historic period has been driven by lack of alternative therapies for ada scid, early success of enzyme replacement therapy • Market expansion is supported by advancements in genetic screening, rising rare disease awareness • Growth Driver: Increasing Precision Medicine Adoption Drives Adagen Market's Growth And Demand • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Adagen Market?

Adagen is a brand name for pegademase bovine, an enzyme replacement therapy used to treat severe combined immunodeficiency (SCID) caused by adenosine deaminase deficiency. It is used for supporting immune function in individuals with SCID, helping to reduce the risk of life-threatening infections by replenishing the missing enzyme necessary for proper immune system development. The main products in adagen are pre-filled and vial. Pre-filled refers to a form of the medication that is supplied in a ready-to-use syringe or device, ensuring convenience and precise dosing for patients. It is primarily used for treating clinical indications such as severe combined immunodeficiency (SCID) and other rare genetic disorders. adagen is employed across various settings, including hospitals and healthcare institutions, specialty clinics, home healthcare services, and research institutions.

What Is The Adagen Market Growth Forecast?

The adagen market size is expected to see strong growth in the next few years. It will grow to $0.13 million in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to advancements in genetic screening, rising rare disease awareness, expansion of specialty immunology clinics, supportive reimbursement frameworks, increased investment in orphan drugs. Major trends in the forecast period include sustained use in rare immunodeficiency disorders, growing emphasis on enzyme replacement therapies, increasing long term scid patient management, rising integration of supportive immunology care, enhanced focus on pediatric rare disease treatment.

Global Adagen Market Segmentation

1) By Product: Pre-filled, Vial 2) By Clinical Indication: Severe Combined Immunodeficiency (SCID), Other Rare Genetic Disorders 3) By End User: Hospitals And Healthcare Institutions, Specialty Clinics, Home Healthcare Services, Research Institutions

What Are The Drivers Of The Adagen Market?

The increasing adoption of precision medicine is expected to propel the adagen market going forward. Precision medicine refers to an innovative approach to healthcare that tailors medical treatment and prevention strategies to the individual characteristics of each patient. The adoption of precision medicine is driven by advancements in genomic technologies, increased availability of biomarkers, integration of artificial intelligence in healthcare, and growing demand for targeted therapies tailored to individual genetic profiles. Adagen supports the adoption of precision medicine by offering targeted enzyme replacement therapy specifically designed for patients with severe combined immunodeficiency (SCID) caused by adenosine deaminase deficiency, exemplifying tailored treatments for rare genetic disorders. For instance, in February 2024, according to the data from the Personalized Medicine Coalition (PMC), a US-based nonprofit umbrella organization, reported in 2023, the FDA approved 16 new personalized treatments for rare diseases, a significant increase from six approvals in 2022. Therefore, the increasing adoption of precision medicine is propelling the adagen industry. The growing diagnosis of rare diseases is expected to propel the adagen market going forward. Rare diseases are medical conditions that affect fewer than 1 in 2,000 people, often characterized by genetic origins and significant health impacts. The growing diagnosis of rare diseases is driven by advancements in genetic testing technologies, increased awareness among healthcare professionals, improved healthcare infrastructure, and expanded global collaboration in rare disease research. Adagen contributes to the growing diagnosis of rare diseases by providing targeted enzyme replacement therapy for severe combined immunodeficiency (SCID), thereby fostering increased awareness, supporting early diagnosis, and encouraging broader research efforts into rare genetic conditions and their treatments. For instance, in February 2024, according to the Genetic Alliance UK, a UK-based national alliance of organizations, rare conditions, defined as affecting fewer than 1 in 2,000 people, impact over 3.5 million individuals in the UK, with 1 in 17 people experiencing such conditions at some point in their lives. Among the 7,000 identified rare conditions,70% of which affect children and over 30% of affected children die before their fifth birthday due to these severe disorders. Therefore, the growing diagnosis of rare diseases is propelling the adagen industry. Rising healthcare expenditure is expected to drive the adagen market going forward. Healthcare expenditure refers to the total spending on medical services, treatments, and healthcare infrastructure by individuals, governments, and organizations. Rising healthcare expenditure is driven by factors such as advancements in medical technology, an aging population, increased chronic disease prevalence, demand for specialized treatments, and the overall inflation of medical costs. Adagen contributes to healthcare expenditure by offering specialized enzyme replacement therapy for rare genetic disorders, increasing investment in research, patient care, and treatment access for conditions like severe combined immunodeficiency (SCID). For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure in UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, rising healthcare expenditure is driving the adagen industry.

Key Players In The Global Adagen Market

Major companies operating in the adagen market are Leadiant Biosciences Inc.

Regional Insights

North America was the largest region in the adagen market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Adagen Market?

The adagen market consists of sales of single-use vials and ready-to-use syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Adagen Market Report 2026?

The adagen market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the adagen industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.